---
schema_version: "secwatch.filing_event.v1"
accession: "0000917520-24-000121"
form_type: "8-K"
ticker: "IART"
cik: "0000917520"
company_name: "INTEGRA LIFESCIENCES HOLDINGS CORP"
filed_at: "2024-12-17T23:59:59+00:00"
generated_at: "2026-05-29T02:40:49.111902+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Integra LifeSciences adopts Change in Control Severance Program effective Jan 1, 2025, renewing expiring program

## Summary
- Program covers named executives including CFO Lea Knight, with severance multiple of 2x (1.5x for others) base salary plus target bonus.
- Qualifying termination (without cause or for good reason) within 2 years after a change in control triggers lump-sum severance, prorated bonus, COBRA for 18 months, and outplacement.
- Program term runs through Dec 31, 2025, with automatic extension upon a change in control until 2-year anniversary.
- Benefits subject to general release of claims and potential 'best pay cap' reduction for excise tax under Section 4999.

## SEC filing metadata
- accession: 0000917520-24-000121
- form_type: 8-K
- ticker: IART
- cik: 0000917520
- company_name: INTEGRA LIFESCIENCES HOLDINGS CORP
- filed_at: 2024-12-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/917520/000091752024000121/0000917520-24-000121-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/917520/000091752024000121/iart-20241212.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000917520-24-000121
- JSON: https://secwatch.observer/filing/0000917520-24-000121.json
- Plain text: https://secwatch.observer/filing/0000917520-24-000121.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.